Explainer

Can GLP-1 Medications Help Fertility If You Have PCOS (Now Called PMOS)?

If you have PCOS, now increasingly called PMOS, and you are on or considering a GLP-1 medication, you have probably wondered whether it could help you get pregnant. Here is a plain-language look at what recent research does and does not say.

The short answer

Early research suggests GLP-1 medications may support fertility for some women with PCOS by improving weight, insulin sensitivity, and cycle regularity, all of which can influence ovulation. But these drugs are not fertility treatments, they are not used during pregnancy, and the evidence is still early. Nothing here is a recommendation to start, stop, or change any medication.

Why PCOS is now being called PMOS

You may see two names for the same condition. A global panel of clinicians, researchers, and patient advocates has formally renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome, or PMOS, a condition that affects about one in eight women. The reasoning is that the old name over-emphasized ovarian cysts and hid the fact that this is a whole-body hormonal and metabolic condition, which can delay diagnosis and care.

That reframing matters for fertility. As Cleveland Clinic describes it, PMOS causes irregular periods, excess androgen levels, and infertility, and insulin resistance is a common feature. When experts talk about targeting the underlying metabolic drivers, especially insulin resistance, alongside reproductive goals, that is exactly the territory where GLP-1 medications enter the conversation.

How GLP-1 medications fit into the picture

GLP-1 receptor agonists such as semaglutide and tirzepatide were developed for type 2 diabetes and weight management. They lower blood sugar, reduce appetite, and often lead to meaningful weight loss. In PMOS, excess weight and insulin resistance can worsen hormone imbalances that interfere with regular ovulation, so it is biologically plausible that improving those factors could help cycles become more predictable.

If your periods shifted after starting one of these medications, that is common and worth understanding on its own. We cover it separately in why your period may change after starting a GLP-1 medication.

What the newest research shows

Reviews and meta-analyses of GLP-1 receptor agonists in women with PCOS report improvements in weight and metabolic markers, and some point to better menstrual regularity. In mid-2026, researchers at the University of Colorado Anschutz reported that injectable semaglutide showed early promise for improving fertility in women with PMOS.

Two cautions are important. First, this is early-stage work, not proof that a GLP-1 will help any individual conceive. Second, most of the strongest signals come through weight loss and insulin improvements rather than a direct fertility effect, so results vary widely from person to person.

The pregnancy question women keep asking

Here is the tension. GLP-1 medications may improve the conditions that make conception more likely, yet they are generally not used during pregnancy, and guidance typically advises stopping before trying to conceive. That is why some women who become more fertile on these drugs can be caught off guard. This is closely related to the reports of unexpected pregnancies we discuss in whether GLP-1 medications can make your birth control pill less effective.

If pregnancy is a goal, the timing of when to stop, and how to manage the transition, is a conversation for you and your own clinician. There is no single right answer, and it depends on your health, your medication, and your plans.

What women may want to track

Because responses are so individual, patterns are more useful than one-off observations. Some women find it helpful to keep a simple record of cycle length, ovulation signs, weight, dose changes, and side effects, so they and their clinician can see whether things are shifting over time. A cycle-aware tracker like PepFem can make that easier by keeping doses, symptoms, and your cycle in one place, and you can read more about the approach in our guide to tracking peptides and GLP-1s alongside your cycle.

The bottom line: for some women with PMOS, GLP-1 medications may indirectly support fertility by improving weight and insulin sensitivity, but the science is early, these are not fertility drugs, and the pregnancy timing question deserves careful, individualized guidance.

Frequently asked questions

Do I have to stop a GLP-1 medication before trying to conceive?

GLP-1 medications are generally not used during pregnancy, and most guidance suggests stopping them before trying to conceive. The specific timing is a personal decision to make with your own clinician.

Is PMOS the same thing as PCOS?

Yes. PMOS, or polyendocrine metabolic ovarian syndrome, is the new name that a global expert panel gave to the condition formerly called polycystic ovary syndrome. Most existing PCOS information still applies.

Can losing weight on a GLP-1 make my periods more regular?

For some women with PMOS, weight loss and better insulin sensitivity are linked to more regular cycles and ovulation, but responses vary a lot from person to person.

Are GLP-1 medications approved as a fertility treatment?

No. They are approved for type 2 diabetes and weight management, not for fertility, so any fertility-related use would be outside their approved purpose.

PepFem is coming soon

The cycle-aware peptide & GLP-1 tracker built for women, on iPhone.

Get launch updates
This article is general education, not medical advice. PepFem is a personal tracking tool, not a healthcare provider or medical device, and nothing here recommends any peptide, dose, or protocol. Always talk to a licensed healthcare professional before starting, stopping, or changing anything.